(Q35936887)

11 August 2017

1 reference

title

Cannabis-associated psychosis: current status of research (English)

1 reference

11 August 2017

1 reference

Joachim Klosterkötter

series ordinal

3

object named as

Joachim Klosterkötter

1 reference

11 August 2017

F Markus Leweke

1

1 reference

PubMed ID

15521792

11 August 2017

Christoph W Gerth

series ordinal

2

1 reference

11 August 2017

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

18

1 reference

11 August 2017

13

1 reference

11 August 2017

895-910

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200418130-00005

11 August 2017

0 references

cites work

The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being

1 reference

12 December 2020

1 reference

12 December 2020

Substance use in young adults with schizophrenic disorders

1 reference

12 December 2020

Cannabis use and psychosis.

1 reference

12 December 2020

Sigma receptors: biology and function

1 reference

12 December 2020

The neurobiology of slow synaptic transmission

1 reference

12 December 2020

Cannabinoid receptor localization in brain

1 reference

12 December 2020

Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function.

1 reference

12 December 2020

Mesolimbic dopaminergic decline after cannabinoid withdrawal

1 reference

12 December 2020

Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County

1 reference

12 December 2020

Schizophrenia: lifetime co-morbidity in a community sample.

1 reference

12 December 2020

Cannabis and acute psychosis.

1 reference

12 December 2020

Adenosinergic psychopharmaceuticals?

1 reference

12 December 2020

Cannabis psychosis following bhang ingestion

1 reference

12 December 2020

Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man

1 reference

12 December 2020

Human hepatic microsomal metabolism of delta 1-tetrahydrocannabinol

1 reference

12 December 2020

Blockade of cannabinoid (CB1) receptors by 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils

1 reference

12 December 2020

Cholecystokinin and schizophrenia

1 reference

12 December 2020

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

1 reference

12 December 2020

Pharmacology and effects of cannabis: a brief review

1 reference

12 December 2020

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

12 December 2020

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

12 December 2020

The endocannabinoid system as a target for therapeutic drugs.

1 reference

12 December 2020

Cannabis consumption as a prognostic factor in schizophrenia

1 reference

12 December 2020

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

1 reference

12 December 2020

Modulation of transmitter release via presynaptic cannabinoid receptors

1 reference

12 December 2020

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

12 December 2020

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

12 December 2020

Pharmacology of cannabinoid receptors

1 reference

12 December 2020

Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors

1 reference

12 December 2020

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

1 reference

12 December 2020

Endogenous cannabinoid signaling and psychomotor disorders

1 reference

12 December 2020

Psychosis and cannabis abuse in The Gambia. A case-control study.

1 reference

12 December 2020

A retrospective study of symptom patterns of cannabis-induced psychosis

1 reference

12 December 2020

Endocannabinoid signaling in the brain

1 reference

12 December 2020

Diazepam treatment of early signs of exacerbation in schizophrenia.

1 reference

12 December 2020

Substance use among the mentally ill: prevalence, reasons for use, and effects on illness

1 reference

12 December 2020

Constituents of Cannabis sativa L. VIII: Possible biological application of a new method to separate cannabidiol and cannabichromene

1 reference

12 December 2020

Psychiatric symptoms in cannabis users

1 reference

12 December 2020

Determination and characterization of a cannabinoid receptor in rat brain

1 reference

12 December 2020

Drug abuse and mental illness.

1 reference

12 December 2020

Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules

1 reference

12 December 2020

Cannabis and psychotic illness

1 reference

12 December 2020

Cannabis use in a large sample of acute psychiatric admissions.

1 reference

12 December 2020

Cannabis and psychosis. Is there epidemiological evidence for an association?

1 reference

12 December 2020

Pharmacological and biochemical interactions between opioids and cannabinoids.

1 reference

12 December 2020

Cannabis and schizophrenia

1 reference

12 December 2020

The endogenous cannabinoid system controls extinction of aversive memories

1 reference

12 December 2020

Transference love: an artificial rose?

1 reference

12 December 2020

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

1 reference

12 December 2020

Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system.

1 reference

12 December 2020

A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses

1 reference

12 December 2020

Psychosis due to "skunk".

1 reference

12 December 2020

The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well-Being.

1 reference

12 December 2020

A 12-step treatment approach for marijuana (Cannabis) dependence

1 reference

12 December 2020

First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression

1 reference

12 December 2020

Patterns of current and lifetime substance use in schizophrenia.

1 reference

12 December 2020

Excitatory amino acids and neuropsychiatric disorders

1 reference

12 December 2020

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

1 reference

12 December 2020

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials

1 reference

12 December 2020

The neurobiology and evolution of cannabinoid signalling

1 reference

12 December 2020

Clinical profile of participants in a brief intervention program for cannabis use disorder

1 reference

12 December 2020

Elevated endogenous cannabinoids in schizophrenia

1 reference

12 December 2020

Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis

1 reference

12 December 2020

Cannabis is not equivalent to cannabinoids

1 reference

12 December 2020

Psychiatric aspects of cannabis use in adolescents and young adults

1 reference

12 December 2020

Cannabis psychosis in young psychiatric inpatients.

1 reference

12 December 2020

Cannabis induced dopamine release: an in-vivo SPECT study

1 reference

12 December 2020

Cannabis use and psychosis: a longitudinal population-based study.

1 reference

12 December 2020

Aversion therapy of cannabis dependence in Nigeria

1 reference

12 December 2020

Psychotic reactions following cannabis use in East Indians.

1 reference

12 December 2020

Cannabis abuse as a risk factor for depressive symptoms

1 reference

12 December 2020

Cannabis and schizophrenia: results of a follow-up study.

1 reference

12 December 2020

Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.

1 reference

12 December 2020

Endorphins and schizophrenia

1 reference

12 December 2020

Neuropeptides, dopamine, and schizophrenia

1 reference

12 December 2020

A second endogenous cannabinoid that modulates long-term potentiation

1 reference

12 December 2020

Carbamazepine adjunct for nonresponsive psychosis with prior hallucinogenic abuse

1 reference

12 December 2020

1 reference

12 December 2020

Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment

1 reference

12 December 2020

Adverse effects of cannabis

1 reference

12 December 2020

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

1 reference

12 December 2020

Cannabis induced psychosis

1 reference

12 December 2020

A community survey of adverse effects of cannabis use.

1 reference

12 December 2020

The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic?

1 reference

12 December 2020

The Interaction Between GABA and Dopamine: Implications for Schizophrenia

1 reference

12 December 2020

Cannabis psychoses in south Sweden.

1 reference

12 December 2020

Schizophrenia and substance abuse

1 reference

12 December 2020

Cannabis-associated psychosis with hypomanic features

1 reference

12 December 2020

Psychosis from alcohol or drug abuse

1 reference

12 December 2020

Adverse reactions to marihuana. Classification and suggested treatment.

1 reference

12 December 2020

Cannabis consumption and schizophrenia

1 reference

12 December 2020

A heuristic vulnerability/stress model of schizophrenic episodes

1 reference

12 December 2020

Does clinical case management improve outpatient addiction treatment

1 reference

12 December 2020

Influence of cannabis abuse on schizophrenic psychopathology

1 reference

12 December 2020

Substance abuse among the chronic mentally ill.

1 reference

12 December 2020

The neurobiology of dopamine signaling

1 reference

12 December 2020

Cannabis use and dimensions of psychosis in a nonclinical population of female subjects

1 reference

12 December 2020

Forty-six cases of psychosis in cannabis abusers

1 reference

12 December 2020

Cannabis is more than simply delta(9)-tetrahydrocannabinol

1 reference

12 December 2020

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective

1 reference

12 December 2020

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

12 December 2020

Localization of cannabinoid receptor mRNA in rat brain

1 reference

12 December 2020

Cannabis Psychosis: a case report

1 reference

12 December 2020

Drug abuse in schizophrenic patients: clinical correlates and reasons for use.

1 reference

12 December 2020

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone

1 reference

12 December 2020

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

1 reference

12 December 2020

The endogenous cannabinoid system and brain development

1 reference

12 December 2020

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

12 December 2020

Marijuana use in schizophrenia: a clear hazard

1 reference

12 December 2020

Psychiatric effects of hashish.

1 reference

12 December 2020

Novel antipsychotic drugs share high affinity for sigma receptors

1 reference

12 December 2020

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

1 reference

12 December 2020

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

1 reference

12 December 2020

The pharmacology and toxicology of atypical antipsychotic agents

1 reference

12 December 2020

Marihuana-Modified Mania

1 reference

12 December 2020

Psychosis after cannabis abuse

1 reference

12 December 2020

Carbamazepine as an adjunct in the treatment of schizophrenia-like psychosis related to cannabis abuse

1 reference

12 December 2020

Toxic cannabis psychosis is a valid entity

1 reference

12 December 2020

Cannabis Psychosis and Paranoid Schizophrenia

1 reference

12 December 2020

Cannabis and schizophrenia. A longitudinal study of Swedish conscripts

1 reference

12 December 2020

CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia

1 reference

12 December 2020

Prevalence estimates of substance abuse in schizophrenia and their correlates

1 reference

12 December 2020

Effects of unsaturated side-chain analogs of tetrahydrocannabinol on cytochromes P450.

1 reference

12 December 2020

Neurotensin and the mesocorticolimbic dopamine system

1 reference

12 December 2020

Marihuana psychosis. Acute toxic psychosis associated with the use of Cannabis derivatives

1 reference

12 December 2020

Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences

1 reference

12 December 2020

CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia

1 reference

12 December 2020

Neurotransmitter interactions in schizophrenia-therapeutic implications

1 reference

12 December 2020

Cannabinoids and neuroinflammation

1 reference

12 December 2020

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

1 reference

12 December 2020

Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia

1 reference

12 December 2020

10.2165/00023210-200418130-00005

Identifiers

DOI

1 reference

PubMed ID

15521792

Dimensions Publication ID

11 August 2017

0 references

1 reference

PubMed ID

15521792